Livestock drugs manufacturer Elanco has confirmed its entry into Kenya after receiving a Sh286 million grant from the Bill and Melinda Gates Foundation.
Elanco Animal Health said it would target smallholder farmers in Kenya while using the country as a hub to expand into Uganda and Tanzania.
The firm, a division of listed Fortune 500 company Eli Lilly and Company, said it will target dairy and poultry enterprises popular with smallholder farmers.
Elanco Animal Health president Jeffrey Simmons said the grant would further advance the firm’s vision to improve the lives of smallholder farmers through sustainable livestock production.
Animal drugs are currently manufactured by the government-owned Kenya Veterinary Vaccines Production Institute, Twiga Chemicals, Biodeal, Eagle Vet, Cosmos, Dawa and Coopers among others.
Elanco currently operates in 70 countries in Europe, Asia, US and Latin America.
The announcement came months after US animal feeds manufacturer Land O'Lakes announced entering a joint venture with Kenyan-based detergents and edible oils conglomerate Bidco Africa to produce and sell animal feeds to local farmers.
The deal underlines the growing interest in the local livestock sector that has grown consistently for years.